Bone Biologics Corp (NASDAQ: BBLG)
$0.9305
-0.0195 ( -0.05% ) 98.5K
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Market Data
Open
$0.9305
Previous close
$0.9500
Volume
98.5K
Market cap
$2.34M
Day range
$0.9110 - $0.9900
52 week range
$0.8000 - $6.3400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 17 | Dec 13, 2024 |
10-q | Quarterly Reports | 57 | Nov 14, 2024 |
8-k | 8K-related | 16 | Oct 21, 2024 |
4 | Insider transactions | 1 | Oct 18, 2024 |
3 | Insider transactions | 1 | Oct 18, 2024 |
8-k | 8K-related | 14 | Oct 04, 2024 |
8-k | 8K-related | 18 | Sep 27, 2024 |
8-k | 8K-related | 14 | Sep 19, 2024 |
4 | Insider transactions | 1 | Sep 19, 2024 |
4 | Insider transactions | 1 | Sep 19, 2024 |